Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. P.A. (Paul) van der Zwaag

Publications

Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?: an early follow-up marker?

ECG-only Explainable Deep Learning Algorithm Predicts the Risk for Malignant Ventricular Arrhythmia in Phospholamban Cardiomyopathy

High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients

Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis

Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study

A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers

Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy

Phenotypic and Genetic Factors Associated with Absence of Cardiomyopathy Symptoms in PLN:c.40_42delAGA Carriers

Phenotypic variability of filamin C–related cardiomyopathy: Insights from a novel Dutch founder variant

SEPT–GD: A decision tree to prioritise potential RNA splice variants in cardiomyopathy genes for functional splicing assays in diagnostics

Read more

Press/media

Kwart miljoen opgehaald voor onderzoek naar Friese ziekte: 'Het ontwricht hele families'

Gaspedaal van het hart